Literature DB >> 13608398

The use of glutethimide (doriden) in obstetrics.

J S BENNETT.   

Abstract

Entities:  

Keywords:  HYPNOTICS AND SEDATIVES/therapeutic use; LABOR/anesthesia and analgesia; PREGNANCY/complications

Mesh:

Substances:

Year:  1959        PMID: 13608398      PMCID: PMC1830369     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  11 in total

1.  [Pharmacological characteristics of the soporific doriden].

Authors:  F GROSS; J TRIPOD; R MEIER
Journal:  Schweiz Med Wochenschr       Date:  1955-03-26

2.  Clinical trial of doriden, a new hypnotic; with note on use of ranking methods in assessing therapeutic effect.

Authors:  M RUSHBROOKE; E S WILSON; J D ACLAND; G M WILSON
Journal:  Br Med J       Date:  1956-01-21

3.  Doriden; a clinical study.

Authors:  E MATLIN
Journal:  Med Times       Date:  1956-01

4.  Clinical observations with a new non-barbiturate-hypnotic agent (glutethimide) in preoperative sedation and in certain selected patients.

Authors:  J HODGE; B F HASKELL; H ROVNER
Journal:  Am J Surg       Date:  1957-07       Impact factor: 2.565

5.  Use of glutethimide for preoperative medication in children.

Authors:  D R BRANCH; R R PASTORELLO
Journal:  N Engl J Med       Date:  1957-07-18       Impact factor: 91.245

6.  Balanced obstetric analgesia.

Authors:  W E CRISP; G L DEAVER; N VORYS
Journal:  GP       Date:  1958-03

7.  Alph-aethyl-alpha-phenyl-glutarmide (doriden) as a sedative agent for precystoscopic sedation.

Authors:  V H BORROMEO; H M BURROS
Journal:  J Urol       Date:  1956-10       Impact factor: 7.450

8.  Variables in the clinical evaluation of a hypnotic drug with a clinical evaluation of glutethimide.

Authors:  S POLLACK; M TAKAKJIAN
Journal:  J Nerv Ment Dis       Date:  1955-12       Impact factor: 2.254

9.  An electroencephalographic study of doriden.

Authors:  H A LADWIG
Journal:  AMA Arch Neurol Psychiatry       Date:  1955-10

10.  Clinical observations with a new sedative-hypnotic agent in elderly and chronically ill patients.

Authors:  R A LANE
Journal:  N Y State J Med       Date:  1955-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.